Dr. Kacskovics has served as a Vice Chairman of ImmunoGenes and as the company's Chief Executive Officer since August 2008, and has served as Chairman since October 2014. Dr. Kacskovics received his DVM degree in 1987, and his PhD (immunology) in 1998 from the University of Veterinary Science, Budapest where he worked as a senior scientist until 2006. He spent his postdoctoral training at the University of Iowa from 1991 to 1994, and has been a visiting scientist at the Karolinska Institute since 1995. Since 2006, he has been an Associate Professor at the Department of Immunology, Eötvös Loránd University, Budapest. Dr. Kacskovics is an expert in immunoglobulins and Fc receptors areas and has been published in over 40 peer-reviewed publications.
Dr. Barlage has served as a director of ImmunoGenes since May 2010 and as Chief Financial Advisor since 2011.
Dr. Barlage has been Managing Partner at PolyTechnos since 2003. He adds an investment and financial analytical capability as well as an operational expertise which is truly unique.
He came to PolyTechnos as one of the most successful executives in the German Engineering field and has built the world's leading hydraulics company Sauer from its German, family-owned mid-cap beginnings to its presence on world stage and public markets. He served as President, COO, and CFO of Sauer, which he took public in 1998 (NYSE: SHS) and which merged with Danfoss Mobile Hydraulics in 2000, creating a company with more than a USD 1B market cap. Sauer is one of the world's largest manufacturers of mobile hydraulic equipment, with operations in the U.S., Europe, Eastern Europe, and Asia. Tonio created the Slovakia and China divisions.
Until 1986, he was audit division manager at Arthur Andersen in Düsseldorf, Germany. He has long standing expertise as a board member and his current appointments include DBD, Nanotron, Innolume, and Panoratio, as well as Framepool.
Dr. Barlage received his graduate degree in electrical engineering and his Ph.D. in business administration from the Technical University of Berlin. He also is a Certified Public Accountant and a Certified Tax Adviser.
Dr. Nagy joined ImmunoGenes in 2012 as a senior scientist. She graduated with an undergraduate degree in biology and received her PhD in Oncology from Semmelweis University of Medicine in Budapest. She conducted her PhD training between 2002 and 2003 at St. Jude Children’s Research Hospital in Memphis, Tennessee, USA focusing on cell signaling mechanism of death receptors in colon carcinomas.
Thereafter she worked as a postdoctoral fellow in Semmelweis University of Medicine in the Department of 1st Institute of Pathology and Experimental Cancer Research, where she continued her work as senior scientist in Research and Development Projects from 2006 until joining ImmunoGenes.
Dr. Nagy has wide experience in cell and tissue culture and also in molecular biology techniques. As a senior scientist, she participated in several important R&D projects, was responsible for project management for other R&D projects and has already managed several mono- and polyclonal antibody development projects for ImmunoGenes.